Q97761054

Summary

Q97761054 is a committee group motion^[1].

Key Facts

• Q97761054 authored Karin Rågsjö^[2].
• Q97761054 authored Nooshi Dadgostar^[3].
• Q97761054 authored Rossana Dinamarca^[4].
• Q97761054 authored Lotta Johnsson Fornarve^[5].
• Q97761054 authored Maj Karlsson^[6].
• Q97761054 authored Linda Westerlund Snecker^[7].
• Q97761054's instance of is recorded as committee group motion^[8].
• Q97761054's part of the series is recorded as motions of 2016-2017 legislative session of the Riksdag^[9].
• Q97761054's language of work or name is recorded as Swedish^[10].
• Q97761054 was published on +2016-12-14T00:00:00Z^[11].
• Q97761054's main subject is medication^[12].
• Q97761054's work available at URL is recorded as http://data.riksdagen.se/dokument/H4023560^[13].
• Q97761054's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H4023560^[14].
• Q97761054's applies to jurisdiction is recorded as Sweden^[15].
• Q97761054's legal citation of this text is recorded as Mot. 2016/17:3560^[16].
• Q97761054's title is recorded as med anledning av skr. 2016/17:39 Riksrevisionens rapport om säkra och effektiva läkemedel^[17].
• Q97761054's maintained by WikiProject is recorded as Project Riksdagen's documents^[18].
• Q97761054's copyright status is recorded as public domain^[19].
• Q97761054's legislative committee is recorded as Committee on Health and Welfare^[20].

Body

Definition and Type

Q97761054's instance of is recorded as committee group motion^[8].